Enhanced antimicrobial effects of carvacrol against methicillin-resistant Staphylococcus aureus strains using niosome formulations

被引:0
|
作者
Bakhtiari, Ronak [1 ,4 ]
Shiri, Maliheh [1 ,4 ]
Mohammadi, Mohammad Reza [2 ,4 ]
Pourmand, Mohammad Reza [1 ,4 ]
Mirzaie, Amir [3 ,4 ]
Taghiabadi, Zahra [3 ,4 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Pathobiol, Div Microbiol, Tehran, Iran
[2] Tarbiat Modares Univ, Fac Med Sci, Dept Bacteriol, Tehran, Iran
[3] Islamic Azad Univ, Dept Biol, Parand Branch, Parand, Iran
[4] Univ Tehran Med Sci, Res Ctr Clin Virol, Tehran, Iran
来源
REVISTA ARGENTINA DE MICROBIOLOGIA | 2025年 / 57卷 / 01期
关键词
Niosome; Carvacrol; Staphylococcus aureus; MIC; MBC; Cell viability; PHYSICOCHEMICAL PROPERTIES; IN-VITRO; DELIVERY;
D O I
10.1016/j.ram.2024.10.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) causes a wide range of infections and contributes to elevated morbidity, mortality, and healthcare costs. Herbal compounds combined with drug delivery systems could be an effective alternative option for treating resistant bacteria. This study evaluates the antimicrobial prowess of carvacrol-loaded niosomes against MRSA strains. In this study, six carvacrol-niosome formulations with different ratios of Span and Tween were prepared. The physicochemical attributes of the optimized synthesized niosomes were assessed using Fourier-transform infrared (FTIR) spectroscopy and scanning electron microscopy (SEM) as well as DLS Zetasizer. Encapsulation efficiency (EE) and in vitro drug release were studied. The antibacterial activity of the synthesized carvacrol-niosomes, in concentrations varying between 7.8 and 1000 mu g/ml, was evaluated using microdilution broth methods. The optimized niosomes, with a size of 207.3 nm and an impressive EE of 91%, exhibited a spherical structure as confirmed by the electron microscopy analysis. Impressively, these carvacrol-niosomes demonstrated superior antimicrobial effectiveness against S. aureus, reducing MIC levels 4-fold to 62.5 f 0.0 mu g/ml and MBC to 125 f 0.0 mu g/ml, a significant improvement over the 250 f 0.0 mu g/ml MIC and 500 f 0.0 mu g/ml MBC of free carvacrol. Additionally, while empty niosomes showed minimal cytotoxicity with 88.32 f 1.32% cell viability at 100 mu g/ml,free carvacrol led to a marked reduction in viability to 39.46 +/- 1.26%. However, niosomes encapsulating carvacrol notably increased cell survival to 59.67 +/- 1.62% at this concentration. These findings underscore the enhanced antimicrobial potency of carvacrol when enclosed within niosomes, suggesting its potential as a potent herbal remedy for combating methicillin-resistant (c) 2024 Published by Elsevier Espana, S.L.U. on behalf of Asociacio<acute accent>n Argentina de Microbiolog<acute accent>& imath;a. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
引用
收藏
页码:39 / 48
页数:10
相关论文
共 50 条
  • [21] Antimicrobial Activity of Different Antimicrobial Peptides (AMPS) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA)
    Ciandrini, Eleonora
    Morroni, Gianluca
    Arzeni, Daniela
    Kamysz, Wojciech
    Neubauer, Damian
    Kamysz, Elzbieta
    Cirioni, Oscar
    Brescini, Lucia
    Baffone, Wally
    Campana, Raffaella
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (24) : 2116 - 2126
  • [22] Synergistic effects of oxyresveratrol in conjunction with antibiotics against methicillin-resistant Staphylococcus aureus
    Joung, Dae-Ki
    Choi, Sung-Hoon
    Kang, Ok-Hwa
    Kim, Sung-Bae
    Mun, Su-Hyun
    Seo, Yun-Soo
    Kang, Da-Hye
    Gong, Ryong
    Shin, Dong-Won
    Kim, Youn-Chul
    Kwon, Dong-Yeul
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 663 - 667
  • [23] Antibacterial and antibiofilm effects of flufenamic acid against methicillin-resistant Staphylococcus aureus
    Zhang, Shutao
    Tang, Haozheng
    Wang, You
    Nie, Bin'en
    Yang, Hongtao
    Yuan, Weien
    Qu, Xinhua
    Yue, Bing
    PHARMACOLOGICAL RESEARCH, 2020, 160
  • [24] Community-associated methicillin-resistant Staphylococcus aureus - evolution of the strains or iatrogenic effects?
    Blazewicz, Izabela
    Baranska-Rybak, Wioletta
    Nowicki, Roman
    PRZEGLAD DERMATOLOGICZNY, 2014, 101 (03): : 181 - 186
  • [25] Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus
    Chen, Zaixing
    Ai, Qin
    Zheng, Shuai
    Chen, Ziyan
    Wang, Sailan
    Zhang, Na
    Liu, Huiping
    Liu, Yanyan
    Li, Jiabin
    Huang, Xiaohui
    FRONTIERS IN MICROBIOLOGY, 2025, 16
  • [26] An Engineered Multimodular Enzybiotic against Methicillin-Resistant Staphylococcus aureus
    Manoharadas, Salim
    Altaf, Mohammad
    Alrefaei, Abdulwahed Fahad
    Ahmad, Naushad
    Hussain, Shaik Althaf
    Al-Rayes, Basel F.
    LIFE-BASEL, 2021, 11 (12):
  • [27] Antimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection
    Kaku, Norihito
    Morinaga, Yoshitomo
    Takeda, Kazuaki
    Kosai, Kosuke
    Uno, Naoki
    Hasegawa, Hiroo
    Miyazaki, Taiga
    Izumikawa, Koichi
    Mukae, Hiroshi
    Yanagihara, Katsunori
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 306 (06) : 421 - 428
  • [28] Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureus
    Hensler, Mary E.
    Jang, Kyoung Hwa
    Thienphrapa, Wdee
    Vuong, Lisa
    Tran, Dan N.
    Soubih, Evaristus
    Lin, Leo
    Haste, Nina M.
    Cunningham, Mark L.
    Kwan, Bryan P.
    Shaw, Karen Joy
    Fenical, William
    Nizet, Victor
    JOURNAL OF ANTIBIOTICS, 2014, 67 (08) : 549 - 553
  • [29] Effect of propolis extracts against methicillin-resistant Staphylococcus aureus
    Saddiq, Amna Ali
    Abouwarda, Ahmed Megahed
    MAIN GROUP CHEMISTRY, 2016, 15 (01) : 75 - 86
  • [30] Methicillin-resistant Staphylococcus aureus infections
    Barry M. Farr
    Current Infectious Disease Reports, 1999, 1 (4) : 328 - 333